glp 1 hospitalization Increased Risk of Heart Failure With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT Trials Improved Heart and Kidney Outcomes

If you reference or share it, please provide a link back to Levity with proper attribution.

Pfizers dose-optimization studies of once-daily formulations of danuglipron (NCT06567327 and NCT06568731) met key pharmacokinetic objectives and confirmed a formulation and dose with the potential to deliver a competitive efficacy and tolerability profile in Phase 3 testing, based on earlier studies of twice-daily danuglipron

Major conclusions: Therefore, this paper reviewed the regulatory effects of GLP-1 on cognitive dysfunction and its possible mechanism

Novo Nordisk

And because the medications work by altering appetite signals, discontinuation frequently leads to weight regain, which highlights the importance of longterm planning and supportive lifestyle changes

President Trump last week hailed his deal with pharma companies to cut the price of blockbuster weight loss drugs as a major win for his administration and for increasing drug affordability